Showing results (431-440 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|December 22, 2015
Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 studyCourtney D DiNardo, Naval Daver, Elias Jabbour, et al.
The Lancet. Haematology|December 22, 2015
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre studyJohn E Levine, Thomas M Braun, Andrew C Harris, et al.
The Lancet. Haematology|December 22, 2015
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort studyTatiana M Lopera-Mesa, Saibou Doumbia, Drissa Konaté, et al.
The Lancet. Haematology|December 22, 2015
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort studyKim Bouillon, Marion Bertrand, Géric Maura, et al.
The Lancet. Haematology|December 22, 2015
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 studyJehan Dupuis, Franck Morschhauser, Hervé Ghesquières, et al.
The Lancet. Haematology|December 22, 2015
Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trialDaryl Tan, Colin Phipps, William Y K Hwang, et al.
The Lancet. Haematology|March 8, 2016
Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests: a single-institution propensity-adjusted cohort studyQing Jia, Michael J Brown, Leanne Clifford, et al.
The Lancet. Haematology|December 23, 2014
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort studyRobert A Kyle, Dirk R Larson, Terry M Therneau, et al.
The Lancet. Haematology|December 8, 2019
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor statesLukasz P Gondek, Amy E DeZern
The Lancet. Haematology|February 7, 2020
Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trialsFrits van Rhee, Corey Casper, Peter M Voorhees, et al.
Pageof 73